Skip to main content
. 2021 Mar 18;81(6):1160–1169.e5. doi: 10.1016/j.molcel.2020.12.048

Table 1.

Potency of sodium current inhibition (IC50) by tamoxifen and related compounds

Drug NavMs, HEK cells D220E, HEK cells E227D, HEK cells NaV1.2, HEK cells MDA-MD-231 cells
Tamoxifen 830 ± 85 nM (1.08 ± 0.1) NT NT 2.4 ± 0.11 μM (1.05 ± 0.1) NT
Endoxifen 328 ± 89 nM (1.09 ± 0.1) NT NT 3.1 ± 0.13 μM (0.97 ± 0.1) NT
4OH-Tam 297 ± 75 nM (1.14 ± 0.1) 3.6 ± 0.14 μM (1.17 ± 0.1) 2.8 ± 0.16 μM (1.13 ± 0.1) 2.1 ± 0.14 μM (0.96 ± 0.1) 889 ± 98 nM (0.98 ± 0.1)
NM-Tam 1.1 ± 0.16 μM (1.11 ± 0.1) NT NT 3.2 ± 0.12 μM (0.96 ± 0.1) NT
E-4OH-Tam 2.3 ± 0.18 μM (1.15 ± 0.1) NT NT 4.2 ± 0.15 μM (0.94 ± 0.1) NT
Z-4OH-Tam 239 ± 87 nM (1.05 ± 0.1) NT NT 1.2 ± 0.12 μM (0.95 ± 0.1) NT
TTX NT NT NT NT 2.6 ± 0.17 μM (1.01 ± 0.1)

Listed are the average IC50 values derived from fitting the dose-response data to the Hill equation. The average slopes of the fits are indicated in parentheses. The drugs tested in the study were tamoxifen, endoxifen, N-desmethyltamoxifen (NM-Tam), 4-hydroxytamoxifen (4OH-Tam), and the E and Z isomers of 4OH-Tam. NT indicates conditions not tested. Error is equal to SD.